Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,087 | 149,042 | 122,971 | 136,708 | 67,358 |
| Marketable Securities | 101,860 | 123,765 | 90,128 | 67,107 | 0 |
| Receivables | 26,841 | 24,699 | 39,136 | 21,469 | 20,648 |
| Income taxes - deferred | N/A | 710 | 409 | N/A | N/A |
| Other current assets | 6,643 | 7,587 | 5,429 | 7,721 | 8,488 |
| TOTAL | $294,431 | $305,803 | $258,073 | $233,005 | $96,494 |
| Non-Current Assets | |||||
| PPE Net | 48,956 | 50,370 | 52,051 | 54,681 | 56,774 |
| Investments And Advances | 7,651 | 0 | 0 | 7,853 | 0 |
| Intangibles | 691 | 653 | 677 | 671 | 662 |
| Other Non-Current Assets | 44,148 | 50,321 | 43,657 | 38,060 | 55,770 |
| TOTAL | $101,446 | $101,344 | $96,385 | $101,265 | $113,206 |
| Total Assets | $395,876 | $407,147 | $354,459 | $334,270 | $209,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,350 | 5,119 | 5,174 | 5,289 | 5,058 |
| Accounts payable and accrued liabilities | 18,511 | 18,213 | 16,051 | 19,069 | 20,476 |
| Other current liabilities | 11,275 | 10,068 | 8,125 | 11,959 | 10,099 |
| TOTAL | $165,650 | $159,633 | $158,447 | $155,144 | $43,953 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,575 | 58,348 | 62,618 | 49,125 | 43,248 |
| Deferred Revenues | 122,006 | 117,754 | 120,556 | 110,325 | 117 |
| Other Non-Current Liabilities | 39,110 | 40,556 | 42,828 | 45,148 | 46,376 |
| TOTAL | $100,803 | $98,904 | $105,446 | $94,431 | $89,624 |
| Total Liabilities | $266,452 | $258,537 | $263,893 | $249,575 | $133,578 |
| Shareholders' Equity | |||||
| Common Shares | 5,906 | 5,897 | 4,376 | 4,365 | 3,492 |
| Retained earnings | -448,481 | -425,356 | -400,165 | -405,766 | -363,191 |
| Other shareholders' equity | -35,154 | -38,077 | -37,241 | -36,689 | -37,503 |
| TOTAL | $129,424 | $148,610 | $90,566 | $84,695 | $76,123 |
| Total Liabilities And Equity | $395,876 | $407,147 | $354,459 | $334,270 | $209,701 |